621 extractive question-and-answer pairs built from 2.1. Phase I - Laboratory evaluation, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 315 of the 621 pairs (50.7%) are explanatory questions and 306 restate a figure. 98.39% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/phase-i-laboratory-evaluation-protocol-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("phase-i-laboratory-evaluation-protocol-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 621 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What criteria are used to evaluate new products for the national vector-borne disease control programme? | based on robust scientific evaluations via laboratory and field trials on their bio-efficacy and effectiveness (on target and non-target organisms) | Therefore, the Indian Council of Medical Research (ICMR) and the National Centre for Vector Borne Diseases Control (NCVBDC) had taken the onus to evaluate and introduce new insecticides or formulations and insecticide-treated/incorporated materials into the national vector-borne disease control programme. The new products are based on robust scientific evaluations via laboratory and field trials on their bio-efficacy and effectiveness (on target and non-target organisms). Prof. | 328 | definition | 1.000 | The new products are based on robust scientific evaluations via laboratory and field trials on their bio-efficacy and effectiveness (on target and non-target organisms). | 6 | page=6,block=0 | 0.850 | valid |
| What is not required for candidate second-in-class products during their assessment? | not required to provide epidemiological data for their assessment | Subsequent products that demonstrate the same entomological effect as the first-in-class products are referred to as “second-in-class” products. Candidate second-in-class products are not required to provide epidemiological data for their assessment. Instead, they are assessed by the WHO Prequalification Unit (PQT) based on their safety, quality and entomological efficacy data (WHO, 2017a) (definition taken from WHO/CDS/GMP/2018.22. | 184 | definition | 1.000 | Candidate second-in-class products are not required to provide epidemiological data for their assessment. | 32 | page=32,block=15 | 0.850 | valid |
| What calculation determines the recovery rate of mosquitoes? | the number of mosquitoes recaptured out of the total number released multiplied by 100 | The next day morning mosquitoes are recaptured. Recovery rate is the number of mosquitoes recaptured out of the total number released multiplied by 100. A recovery rate of at least 70% ensures the tightness of the hut. | 65 | definition | 1.000 | Recovery rate is the number of mosquitoes recaptured out of the total number released multiplied by 100. | 67 | page=67,block=6 | 0.850 | valid |
| What is the denominator used to calculate survivorship rates for LLINs? | the total number of LLINs of each arm distributed to the surveyed households in the study cohort at the beginning of the study | The following indicators should be used and disaggregated by survey time (e.g., 6, 12, 24 or 36 months, or more if necessary): 1.1.3.2 Attrition rates (survivorship of nets in households) The numerator is the total number of LLINs of each arm (candidate or positive control/reference LN) present in the surveyed households (and available for sleeping under) × 100. The denominator is the total number of LLINs of each arm distributed to the surveyed households in the study cohort at the beginning of the study. Survivorship rate = (LLIN present during the survey /LLINs Distributed) × 100 Attrition is calculated as 1 minus survivorship. | 384 | definition | 1.000 | The denominator is the total number of LLINs of each arm distributed to the surveyed households in the study cohort at the beginning of the study. | 86 | page=86,block=2 | 0.850 | valid |
| What is the candidate LN considered to have met based on entomological parameters? | considered to have met the WHO efficacy criteria based only on entomologi cal parameters | The net will be considered to have failed to meet WHO criteria if >20% of the nets sampled fail to meet the criteria, the study will be stopped. The candidate LN is considered to have met the WHO efficacy criteria based only on entomologi cal parameters. The data on malaria prevalence and incidence can be additional parameters not amounting to the failure of the net. | 165 | definition | 1.000 | The candidate LN is considered to have met the WHO efficacy criteria based only on entomologi cal parameters. | 88 | page=88,block=11 | 0.850 | valid |
| What can be used for bioassays if wild caught female mosquitoes are insufficient in number? | not available in sufficient number for bioassays, the F1 progeny of wild caught mosquitoes can be used | Twenty-five (mixed age) wild caught female mosquitoes are released into each cage and exposed to insecticide application for 60 minutes in both experiment and control houses. If wild caught females are not available in sufficient number for bioassays, the F1 progeny of wild caught mosquitoes can be used. Before insecticide spraying, the external doors and windows of the house should be closed. | 202 | definition | 1.000 | If wild caught females are not available in sufficient number for bioassays, the F1 progeny of wild caught mosquitoes can be used. | 101 | page=101,block=0 | 0.850 | valid |
| What is the purpose of Phase I evaluation in the laboratory? | carried out in the laboratory to assess the efficacy and persistence of ATSB formulations incorporated with a candidate insecticide against laboratory reared target vector species | Phase I evaluation is carried out in the laboratory to assess the efficacy and persistence of ATSB formulations incorporated with a candidate insecticide against laboratory reared target vector species. The ATSB formulation containing 6–7 concentrations of a candidate insecticide should be prepared and evaluated. | 22 | definition | 1.000 | Phase I evaluation is carried out in the laboratory to assess the efficacy and persistence of ATSB formulations incorporated with a candidate insecticide against laboratory reared target vector species. | 129 | page=129,block=4 | 0.850 | valid |
| What is the scope of Phase III trials for ATSBs? | carried out at village level, selecting comparable villages in terms of population, housing structure, mosquito species and density, topography and disease prevalence/incidence | 7.3 Phase III evaluation of ATSBs against Anopheles / Culex vectors (multi- centric) The efficacy of ATSB that showed desired activity in experimental hut or small-scale outdoor field trials (Phase II) should be evaluated in large-scale (at village level) against the target vector mosquitoes at least in three eco-epidemiological settings (multi-centric) covering peak mosquito/ transmission seasons. The Phase III trials are carried out at village level, selecting comparable villages in terms of population, housing structure, mosquito species and density, topography and disease prevalence/incidence. | 427 | definition | 1.000 | The Phase III trials are carried out at village level, selecting comparable villages in terms of population, housing structure, mosquito species and density, topography and disease prevalence/incidence. | 137 | page=137,block=0 | 0.850 | valid |
| What role does the carrier oil play in insecticide-impregnated papers? | allows formation of a stable, thin, and homogeneous layer of the insecticide on the filter-paper and also prevents the crystallization of active ingredients | BDH Dow Corning® 556) for pyrethroids. • Degree of purity of the insecticide (technical grade) to be used should be noted as this is important to calculate the quantity of active ingredient to be mixed with the solvent. • Concentration of insecticide necessary for impregnation should be chosen. • Technical grade insecticide is dissolved in a non-volatile carrier oil, and 0.8 ml of this is mixed with 1.2 ml of acetone (2 ml is the standard volume required per paper), and applied to rectangular pieces of Whatman® No. 1 filter-paper measuring 12 × 15 cm. • The carrier oil allows formation of a stable, thin, and homogeneous layer of the insecticide on the filter-paper and also prevents the crystallization of active ingredients. • Since acetone is volatile, the insecticide concentration is normally expressed as % of active ingredient (ai) per unit volume of carrier oil on the filter-paper. • Example: Papers are impregnated at 3.6 mg/cm² of the carrier oil, i.e., 648 mg/paper of 0.018 m2 or 0.66 ml/paper for silicon oil, having a density of 0.98. | 576 | definition | 1.000 | • The carrier oil allows formation of a stable, thin, and homogeneous layer of the insecticide on the filter-paper and also prevents the crystallization of active ingredients. | ||||
| What does the diagnostic concentration represent in baseline susceptibility tests? | twice the LC99 determined in baseline susceptibility tests against a susceptible laboratory strain or a susceptible field population of mosquitoes | The diagnostic concentration corresponds to twice the lowest concentration that causes 100% mortality after 60 minutes exposure and 24 h holding (or longer if indicated) of a susceptible laboratory strain or a susceptible field population or twice the LC99 determined in baseline susceptibility tests against a susceptible laboratory strain or a susceptible field population of mosquitoes (WHO, 2006). {Note: To obtain the desired concentration, serial dilution may be required. In case, the stock is 95%, but the required concentration is 0.001%, it would be better to prepare 1% stock solution, which is diluted to 0.05%, and by diluting this the final concentration of 0.001% may be achieved. It is to be noted that direct dilution from 1% to 0.001% should be avoided. Accurate weighing of a small quantity of ai, for e.g., <10mg, on micro balance would be difficult. | 242 | definition | 1.000 | The diagnostic concentration corresponds to twice the lowest concentration that causes 100% mortality after 60 minutes exposure and 24 h holding (or longer if indicated) of a susceptible laboratory strain or a susceptible field population or twice the LC99 determined in baseline susceptibility tests against a susceptible laboratory strain or a susceptible field population of mosquitoes (WHO, 2006). |
Read straight from the file — download or use the API URL for the full dataset.
| 22 |
| page=22,block=9 |
| 0.700 |
| valid |
| 23 |
| page=23,block=0 |
| 0.700 |
| valid |